Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. 더 보기
Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
12 | -0.725 | -15.7608695652 | 4.6 | 5.705 | 3.15 | 956494 | 3.9668876 | CS |
26 | -0.875 | -18.4210526316 | 4.75 | 9.395 | 3.15 | 1298059 | 5.15119451 | CS |
52 | -13.91 | -78.2119763846 | 17.785 | 23.5 | 3.15 | 817042 | 6.26900135 | CS |
156 | -134.125 | -97.1920289855 | 138 | 227.7725 | 3.15 | 708614 | 17.13843458 | CS |
260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 580615 | 29.01959287 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관